Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Mark R. Hake, CFA

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing

Kenvue, Inc. (KVUE), which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today. 

KVUE is at $21.59 today, well off its highs after releasing disappointing Q1 sales results on May 8. That probably led to the CEO's ouster yesterday. But it could be a value investor's signal to consider buying into KVUE stock.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.